NO995963L - Karboksamider anvendelige som 5-HTIF-agonister - Google Patents

Karboksamider anvendelige som 5-HTIF-agonister

Info

Publication number
NO995963L
NO995963L NO995963A NO995963A NO995963L NO 995963 L NO995963 L NO 995963L NO 995963 A NO995963 A NO 995963A NO 995963 A NO995963 A NO 995963A NO 995963 L NO995963 L NO 995963L
Authority
NO
Norway
Prior art keywords
carboxamides
carboxamides useful
htif
agonists
htif agonists
Prior art date
Application number
NO995963A
Other languages
English (en)
Other versions
NO995963D0 (no
Inventor
Michael Edward Flaugh
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO995963L publication Critical patent/NO995963L/no
Publication of NO995963D0 publication Critical patent/NO995963D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Den foreliggende oppfinnelsen tilveiebringer nye 2-amino-l,2,3,4-tetrahydro-9H- karbazol-6-karboksamider og 3-amino-1 OH-cyklohepta[7,6-b]indol-7-karboksamider med formel (I), hvor R1, R2, R3 og n er som beskrevet i beskrivelsen.
NO995963A 1997-06-04 1999-12-03 Karboksamider anvendelige som 5-HTIF-agonister NO995963D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4858497P 1997-06-04 1997-06-04
PCT/US1998/003340 WO1998055115A1 (en) 1997-06-04 1998-06-01 Carboxamides useful as 5-ht1f agonists

Publications (2)

Publication Number Publication Date
NO995963L true NO995963L (no) 1999-12-03
NO995963D0 NO995963D0 (no) 1999-12-03

Family

ID=21955349

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995963A NO995963D0 (no) 1997-06-04 1999-12-03 Karboksamider anvendelige som 5-HTIF-agonister

Country Status (21)

Country Link
EP (1) EP0882726B1 (no)
JP (1) JP2002502419A (no)
KR (1) KR20010013409A (no)
CN (1) CN1259049A (no)
AT (1) ATE240953T1 (no)
AU (1) AU729786B2 (no)
BR (1) BR9810610A (no)
CA (1) CA2291624A1 (no)
DE (1) DE69814735T2 (no)
DK (1) DK0882726T3 (no)
EA (1) EA001718B1 (no)
ES (1) ES2199410T3 (no)
HU (1) HUP0004142A3 (no)
ID (1) ID23053A (no)
IL (1) IL133279A0 (no)
NO (1) NO995963D0 (no)
NZ (1) NZ501569A (no)
PL (1) PL337221A1 (no)
PT (1) PT882726E (no)
TR (1) TR199903014T2 (no)
WO (1) WO1998055115A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000034266A1 (en) * 1998-12-11 2000-06-15 Eli Lilly And Company Indole derivatives and their use as 5-ht1f agonists
AU3840000A (en) 1999-04-20 2000-11-02 Meiji Seika Kaisha Ltd. Tricyclic compounds
WO2001010381A2 (en) * 1999-08-04 2001-02-15 Icagen, Inc. Methods for treating or preventing pain and anxiety
US6495550B2 (en) 1999-08-04 2002-12-17 Icagen, Inc. Pyridine-substituted benzanilides as potassium ion channel openers
ATE380176T1 (de) 1999-08-04 2007-12-15 Icagen Inc Benzanilide als öffner des kaliumkanals
TWI263497B (en) 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
CN1777584A (zh) 2003-04-18 2006-05-24 伊莱利利公司 作为5－ht1f激动剂的(哌啶氧基)苯基、(哌啶氧基)吡啶基、(哌啶硫基)苯基和(哌啶硫基)吡啶基化合物
UA82711C2 (en) 2003-09-12 2008-05-12 Эли Лилли Энд Компани Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
WO2005061439A1 (en) * 2003-12-17 2005-07-07 Eli Lilly And Company Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists
KR20080044273A (ko) 2005-08-08 2008-05-20 아스텔라스세이야쿠 가부시키가이샤 아실구아니딘 유도체 또는 그의 염
JP5287257B2 (ja) * 2007-02-07 2013-09-11 アステラス製薬株式会社 アシルグアニジン誘導体
WO2011117798A1 (en) * 2010-03-22 2011-09-29 Actelion Pharmaceuticals Ltd 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
CA2795062A1 (en) 2010-04-02 2011-10-06 Colucid Pharmaceuticals, Inc. Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists
CA2909111A1 (en) * 2013-04-09 2014-10-16 Cresset Biomolecular Discovery Ltd The local treatment of inflammatory ophthalmic diseases
AR119319A1 (es) 2019-07-09 2021-12-09 Lilly Co Eli Procesos e intermediario para la preparación a gran escala de hemisuccinato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il]-benzamida y preparación de acetato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il]-benzamida
CN112125836A (zh) * 2020-10-15 2020-12-25 濮阳惠成电子材料股份有限公司 有机电致光电材料中间体n-苯基咔唑-3-羧酸乙酯的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226566D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine
EA001113B1 (ru) * 1995-03-20 2000-10-30 Эли Лилли Энд Компани 5-замещенные-3-(1,2,3,6-тетрагидропиридин-4-ил)- и 3-(пиперидин-4-ил)-1н-индолы и их фармацевтически приемлемые соли и сольваты, фармацевтическая композиция на их основе, способ активации рецепторов 5-нт1 и способ ингибирования нейронной белковой транссудации
DE69610793T2 (de) * 1995-06-23 2001-05-03 Lilly Co Eli 6-Subsitituierte-1,2,3,4-tetrahydro-9H-Carbazole und 7-substituierte-1OH-Cyclohepta(7,6-B)-Indole

Also Published As

Publication number Publication date
ID23053A (id) 2000-01-20
PT882726E (pt) 2003-09-30
WO1998055115A1 (en) 1998-12-10
EA199901113A1 (ru) 2000-08-28
CN1259049A (zh) 2000-07-05
HUP0004142A2 (hu) 2001-05-28
EP0882726B1 (en) 2003-05-21
ES2199410T3 (es) 2004-02-16
NO995963D0 (no) 1999-12-03
HUP0004142A3 (en) 2002-10-28
NZ501569A (en) 2001-11-30
AU729786B2 (en) 2001-02-08
KR20010013409A (ko) 2001-02-26
AU7795598A (en) 1998-12-21
EP0882726A1 (en) 1998-12-09
DE69814735D1 (de) 2003-06-26
DE69814735T2 (de) 2004-03-25
JP2002502419A (ja) 2002-01-22
ATE240953T1 (de) 2003-06-15
PL337221A1 (en) 2000-08-14
EA001718B1 (ru) 2001-08-27
BR9810610A (pt) 2000-09-12
TR199903014T2 (xx) 2000-05-22
DK0882726T3 (da) 2003-09-22
CA2291624A1 (en) 1998-12-10
IL133279A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
NO995963L (no) Karboksamider anvendelige som 5-HTIF-agonister
MX9605128A (es) Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
CA2354023A1 (en) Phenylglycine derivatives
TR200400376T4 (tr) Yeni, ilaç olarak kullanılabilen antikolinerjikler ve bunların imalatı için yöntem
NO970512L (no) Nye heteroaryl-oksazolidinoner
TR199901653T2 (xx) Fitalazinonlar.
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
NZ516599A (en) 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
MX9805181A (es) Derivados de lactona a partir de derivados de 17.beta- carboxi, carbotio y amida androstano.
NO994115L (no) Nye 1,4-diazacykloheptanderivater og deres anvendelse i haaroksydasjonsfargestoffer
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
IL140070A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
IL131581A0 (en) Cycloalkylalkanecarboxamides and the production and use thereof
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
ES2191341T3 (es) Derivados de la 2-fenoxianilina.
NZ326675A (en) Oxazoline arthropodicides
SI1377574T1 (no)
MY132057A (en) Quinoxalinones, a process for their preparation and their use
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
EP0251574A3 (en) Antifungal derivatives of n-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
DK0435235T3 (da) Nye isoquinolinderivater og salte deraf
BG105329A (en) N-substituted azabicycloheptane derivatives, production and use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application